483
Pharmaceutical Innovations, Inc.FDA 483 - Pharmaceutical Innovations, Inc. - June 19, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Pharmaceutical Innovations, Inc. in Newark, NJ, was inspected by the FDA from May 15 to June 19, 2017, revealing significant quality system deficiencies. The firm lacked established procedures for corrective and preventive actions, design control, process validation, and acceptance activities. These issues indicate a systemic failure to ensure product quality and compliance with regulatory requirements for medical device manufacturing.
Open in Dashboard
ID · 355ac9f8-987a-4280-a222-b6d19708c857